Epstein Secrets

at the Capitol, the outlook dimmed." The Hill <https://thehill.com/homenews/senate/509839-mcconnell-tees-up-fight-on-unemployment-benefits> (7/30, Carney, 2.98M) quotes McConnell as saying on the Senate floor, "We've had enough rope a dope. We've had EFTA00136356 enough empty talk. It's time to go o

. The New York Post <https://nypost.corn/2020/07/30/johnson-johnson-starts-human-vaccine-trials-after-monkey- study/> (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmaker

rs (2/22, Chiacu), the New York Post (2/22, Nelson, 7.45M), Axios (2/22, Allassan, 1.26M), Politico (2/22, LeVine, Gerstein, 6.73M), The Hill (2/22, Carney, Beitsch, 5.69M), Roll Call (2/22, Ruger, 130K), and the CNN (2/22, Rogers, Herb, 89.21M) and Fox News (2/22, Raasch, 23.99M) websites are among ot

ication, 8.41M) also have reports. J&J Says It Should Have Enough Doses For More Than 20M By End Of March. The Hill (2/22, Sullivan, 5.69M) reports Johnson & Johnson said Monday that it "plans to have enough doses of its vaccine for more than 20 million Americans by the end of March" if its vaccine is authorized

President Joe Biden will bear fruit," moderates "say the party needs to be more patient and give the centrists some space to work." The Hill (1/26, Carney, 5.69M) and Roll Call (1/26, Krawzak, Lerman, 130K) provide similar coverage. Deese: White House May Agree To Restrict Eligibility For $1,400 Check

uccia, Subscription Publication, 8.41M), Politico (1/26, Cancryn, Roubein, 6.73M), and The Hill (1/26, Sullivan, Samuels, 5.69M) also have reports. Johnson & Johnson Expects To Report Vaccine Data Next Week. Reuters (1/26, Mishra, O'Donnell) reports that on Tuesday, Johnson & Johnson "said it expected to report

nefit while talks on a broader COVID-19 relief measure grind on. But ahead of late-night talks at the Capitol, the outlook dimmed." The Hill (7/30, Carney, 2.98M) quotes McConnell as saying on the Senate floor, "We've had enough rope a dope. We've had enough empty talk. It's time to go on the record."

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake

d News TonightVi (4/22, story 8, 0:20, Muir, 6.07M), the Wall Street Journal (4/22, Peterson, Subscription Publication, 8.41M), and The Hill (4/22, Carney, 5.69M) provide additional coverage. CAPITOL VIOLENCE NEWS Federal Prosecutors Expect At Least 100 More Arrests In Capitol Siege Probe. Reuters (4

ine Use. The Washington Post (4/22, Al, McGinley, Sun, 10.52M) reports, "Federal health authorities are leaning toward recommending that use of the Johnson & Johnson coronavirus vaccine resume, possibly as soon as this weekend - a move that would include a new warning about a rare complication involving blood cl

nefit while talks on a broader COVID-19 relief measure grind on. But ahead of late-night talks at the Capitol, the outlook dimmed." The Hill (7/30, Carney, 2.98M) quotes McConnell as saying on the Senate floor, "We've had enough rope a dope. We've had enough empty talk. It's time to go on the record."

rapid cure for a pathogen like covid-19 for years." Johnson & Johnson Starts Human Vaccine Trials. The New York Post (7/30, O'Neill, 4.57M) reports Johnson & Johnson began human trials of its experimental COVID-19 vaccine on Thursday, "after the shots already proved successful in protecting monkeys, the drugmake